title: The cat as a model for human obesity and diabetes.
abstract: Obesity is the most common nutritional disorder of cats and is a risk factor for diabetes. Similar to developments in obese people, obese cats show peripheral tissue insulin resistance and may demonstrate glucose intolerance when challenged with pharmacological amounts of glucose. However, they compensate well for the insulin resistance and do not show elevated glucose concentrations when monitored during their regular daily routine, including postprandial periods. This is possible because obese cats in the fasted and postprandial state are able to maintain hepatic insulin sensitivity and decrease endogenous glucose production, which allows them to maintain normoglycemia. Also dissimilar to what is seen in many obese humans, cats do not develop atherosclerosis and clinical hypertension. The time course for progression to overt diabetes of obese cats is unknown. One might speculate that diabetes develops when the liver finally becomes insulin resistant and/or insulin secretion becomes too low to overcome increased glucose production. In addition, amyloid, demonstrated to be deposited in islet of chronically obese cats, may contribute to a reduction in insulin secretion by reducing functional β-cell mass.
authors: College of Veterinary Medicine, University of Illinois, Urbana, Illinois 61802, USA. mhoenig@illinois.edu
authors: Margarethe
authors: M
authors: Hoenig
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D002371:Cat Diseases / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology; D002415:Cats; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology / Q000662:veterinary*; D004195:Disease Models, Animal; D018450:Disease Progression; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000097:blood / Q000494:pharmacology; D007333:Insulin Resistance; D050417:Insulin-Secreting Cells / Q000378:metabolism; D009765:Obesity / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology / Q000662:veterinary*; D012307:Risk Factors; D013045:Species Specificity
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin